Trinity Capital heads into its Q1 2026 earnings release — filed today — with short sellers quietly rebuilding positions and the borrow market at its tightest all year, even as the stock has climbed more than 13% over the past month.
The positioning story is striking for a BDC trading at just under $17. Short interest has climbed 8% over the past week to 8.1% of the free float — a meaningful level for this asset class, and up from a base near 5.6% in late March. More telling is the borrow market: availability has collapsed to just 0.35% of short interest, meaning there is virtually no headroom left in the lending pool. Every share available for borrowing is effectively lent out. The cost to borrow reflects the same tightness — currently running at 3.85% annualised, roughly three times where it traded at the start of April (1.15%), though it has pulled back from a recent intraday high above 5.5%. The ORTEX short score of 66 puts TRIN in the sixth percentile of all stocks by short positioning intensity, a level that flags genuine short-seller conviction. Options positioning, meanwhile, has shifted sharply in the other direction: the put/call ratio has fallen to 1.0, well below its 20-day average of 1.44 and the lowest reading in roughly six weeks. That divergence — shorts rebuilding while options hedgers step back — is the central tension this week.
The Street's view on TRIN remains divided. The most recent analyst data (as of mid-April) shows a mean price target of $16.83, fractionally below the current price of $16.97 — a setup that suggests the market has largely priced in the modest consensus upside. The bullish case centres on strategic leverage deployment and growth from off-balance-sheet vehicles, including the firm's RIA structure and joint ventures. Bears point to declining core yields, falling operating earnings relative to estimates, and a 2.2% NAV erosion from $13.35 to $13.05 in recent quarters. Wells Fargo has maintained an Underweight rating throughout, raising its target only marginally to $13.50 last August. UBS holds a Buy but trimmed to $17.00 in October. That mix — a Buy from UBS, a Market Perform from KBW, and a persistent Underweight from Wells — has held the stock in a tight valuation band for most of the past year. Note that the most recent formal analyst actions are from late 2025 and should be treated as background rather than current catalysts. The price-to-book ratio has expanded materially, rising to 1.22x from around 1.11x over the past 30 days, tracking the stock's recovery off its March lows.
Institutional flow adds a further layer. T. Rowe Price added 365,000 shares in the quarter to March 31, a notable position build for a stock of this size. On the other side, Marshall Wace reduced by 706,000 shares and Two Sigma cut by 596,000 — two quantitative managers trimming in the same period the stock was recovering. Insider activity in mid-March told a mixed story too: several executives, including the co-founder and COO, sold shares at $14.42 as part of what appeared to be a scheduled distribution event, while founder Kyle Brown and the Lead Independent Director both bought back smaller quantities three days later at $14.16. The net 90-day insider position is a modest purchase of roughly 114,000 shares ($1.65m), skewed by the buybacks rather than indicating any strong directional conviction.
Today's earnings release — TRIN filed Q1 2026 results after the close — is the immediate watchpoint. The only comparable recent earnings reaction in the data is the February 2026 print, where the stock moved just +1.2% the next day and faded to near flat over the following week. The next scheduled reporting event is June 10. With availability at an extreme and short interest elevated, the key variable to watch is how the Q1 net investment income and NAV figures land against the bear case of declining portfolio yields: a beat or a hold of NAV could pressure short sellers in a thin borrow market; a miss on NII or another NAV step-down would validate the positioning on the other side.
See the live data behind this article on ORTEX.
Open TRIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
